TDOC Teladoc Health, Inc.

NYSE teladochealth.com


$ 8.68 $ -0.11 (-1.26 %)    

Friday, 31-Oct-2025 18:37:56 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 8.63
$ 8.74
$ 8.50 x 5,600
$ 8.70 x 101
$ 8.46 - $ 9.15
$ 6.35 - $ 15.21
9,619,216
na
1.53B
$ 1.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 04-26-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 10-27-2023 09-30-2023 10-Q
10 07-28-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-02-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-01-2021 09-30-2021 10-Q
18 08-02-2021 06-30-2021 10-Q
19 05-03-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 07-30-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 04-30-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-08-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 10-27-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-03-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-in-line-on-teladoc-health-lowers-price-target-to-8

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price targe...

 update-teladoc-health-q3-adj-eps-020-beats-027-estimate-sales-626439m-beat-625913m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.27) ...

 teladoc-health-sees-q4-gaap-eps-025-010-vs-017-est-sees-sales-622000m-652000m-vs-634855m-est

Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.25)-$(0.10) vs $(0.17) analyst estimate. sees sales of $622.000 mi...

 teladoc-health-narrows-fy2025-gaap-eps-guidance-from-135-100-to-125-110-vs-112-est-narrows-fy2025-sales-guidance-from-2501b-2548b-to-2510b-2539b-vs-2522b-est

Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) analyst estimate...

 teladoc-health-q3-eps-028-misses-026-estimate-sales-626439m-beat-625913m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26...

 retail-investors-top-stocks-with-earnings-this-week-sofi-apple-meta-and-more

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites. 

 teladoc-health-reaffirms-its-2025-fy-consolidated-revenue-of-2501b-2548b-and-adjusted-ebita-outlook-issued-on-july-29-2025

In conjunction with this leadership announcement, Teladoc Health reaffirmed its 2025 full-year consolidated revenue and adjuste...

 teladoc-health-announces-cfo-mala-murthy-will-step-down-on-november-21-2025-and-search-has-begun-for-her-successor

Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her ...

 citigroup-maintains-neutral-on-teladoc-health-raises-price-target-to-105

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $9....

 why-teladoc-health-tdoc-stock-is-trading-higher-wednesday

Shares of Teladoc Health Inc (NYSE: TDOC) are trading higher and trending Wednesday afternoon. Here's what investors need t...

 evercore-isi-group-maintains-in-line-on-teladoc-health-raises-price-target-to-9

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and raises the price targe...

 teladoc-tdoc-shares-climb-on-bullish-commentary-from-citron-research

Shares of Teladoc Health are surging Friday morning after Citron Research posted a bullish note on the telehealth provider.

 citron-research-posts-on-x-tdoc--we-were-not-wrong-just-early-reason-for-recent-is-last-time-livongo-maus-were-this-strong-the-stock-was-15-today-its-85-even-as-bofa-just-reported-livongo-usage-55-yy-the-biggest-jump-since-jan-25--livongo-is-the-saas-backbone-of-teladoc-recurring

https://x.com/citronresearch/status/1974106818939920519?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 teladoc-health-announces-it-has-acquired-telecare-financial-terms-not-disclosed

Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Austra...

 teladoc-health-reports-smaller-than-expected-q2-loss-revenue-tops-estimates

Teladoc announces second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million.

 teladoc-health-sees-q3-gaap-eps-035-020-vs-018-est-sees-sales-614000m-636000m-vs-628009m-est

Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.35)-$(0.20) vs $(0.18) analyst estimate. sees sales of $614.000 mi...

 teladoc-health-narrows-fy2025-gaap-eps-guidance-from-140-090-to-135-100-vs-108-est-narrows-fy2025-sales-guidance-from-2468b-2576b-to-2501b-2548b-vs-2517b-est

Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.40)-$(0.90) to $(1.35)-$(1.00) vs $(1.08) analyst estimate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION